Lion Biotechnologies Inc. (LBIO)

[rappinjoeyb]

The biggest shame is any delay that the executive mismanagement of this company causes in getting the TIL cell treatment to those who need it most, patients with advanced stage melanoma. Response rates in trials exceed anything that's been approved by the FDA, including several new therapies in the past two years. The clinical trials will continue regardless and eventually this life-saving therapy will be available to more patients at more locations. One only hopes that the apparent neglect of this particular business doesn't slow the continued testing and inevitable approval of the treatment. There are over 75000 new cases of melanoma in the US every year and more than 9000 Americans will die from it in 2013. This technology developed by brilliant and dedicated physicians and scientists at the NIH can put a dent in that 2nd number.